Terry Sweet
Follow
Get notifications in MyBN when activity occurs.
Terry Sweet
Terry Sweet has been an executive and non-executive director of several listed companies for more than 30 years. These companies include XRF Scientific where he was managing director for 4 years, Western Biotechnology, Heartlink, and Scientific Services. Originally trained as a chemist, his interests and expertise now lie in the area of development and supervision of a culture of board integrity, commensurate with technology commercialisation. Mr Sweet is a Fellow of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 237th | XRF Scientific | 70% | 53% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | XRF Scientific | $59.8m |
200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| REMUNERATION UPDATE: Non-Executive Chair, Proteomics International Laboratories | 02 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Chair, Proteomics International Laboratories | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Chair, Proteomics International Laboratories | 30 Jun 2020 |
News Articles
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Chair | | 2014 - 2021 | |
| Managing Director | | 2007 - 2012 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Proteomics International Laboratories | 29 Mar 2018 | Issued | 1,250,000 | $0.20 | $250,000 | Exercise of options |
| Proteomics International Laboratories | 29 Mar 2018 | Other | 1,250,000 | $0.20 | $250,000 | Exercise of options |
| Proteomics International Laboratories | 23 Mar 2018 | Other | 1,133,875 | OtherOff-market transfer | ||
| Proteomics International Laboratories | 16 Mar 2018 | Other | 375,000 | OtherOff-market transfer | ||
| Proteomics International Laboratories | 28 Dec 2016 | Bought | 50,000 | $0.24 | $12,000 | OtherParticipation in share purchase plan |
Powered by Morningstar ®
Equity Capital Markets Deals
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| 12/11/14 | Proteomics International Laboratories | Initial public offering | $4.0m | >> |
